CTOs on the Move

Union Pacific RR Employes Health Systems

www.uphealth.com

 
Union Pacific RR Employes Health Systems is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

InfraReDx Inc.

InfraReDx Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, MA. To find more information about InfraReDx Inc., please visit www.infraredx.com

United Zion Retirement Comm

United Zion Retirement Comm is a Lititz, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Noom

Noom is the world`s leading behavior change company, disrupting the weight loss and healthcare industries. By combining the power of artificial intelligence, mobile tech, and psychology with the empathy of over 1,000 personal coaches, Noom helps people live healthier lives by changing their long-term habits. More than 50 million people have benefited from Noom`s behavior change courses, including its virtual diabetes prevention program, which was the first of its kind to be recognized by the CDC. The Noom platform is already being used by leading healthcare and pharmaceutical companies to improve treatment outcomes for patients worldwide. The company is headquartered in New York City with offices in Seoul and Tokyo.

Wayne Pharmacy

Wayne Pharmacy is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.